发现了抑制EGFR的强效全性抗体
Léxane Fournier1,2, Lukas Pekar3, Birgitta Leuthner4
1Early Protein Supply and Characterization, Merck Healthcare KGaA, Darmstadt, Germany.
mAbs
|September 21, 2024
概括
研究人员发现了针对表皮生长因子受体 (EGFR) 的新型全性重链抗体. 这些强大的抗体抑制癌细胞信号通路,显示出超越当前治疗的治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 表皮生长因子受体 (EGFR) 是癌症治疗的关键标.
- 现有的EGFR抑制剂经常面临耐药性和副作用.
- 菌抗体提供了一个潜在的替代治疗策略.
研究的目的:
- 发现和描述针对EGFR的新型全性重链抗体.
- 评估这些抗体的结合亲和力和抑制潜力.
- 为了比较一种类全抗体与 cetuximab 的疗效.
主要方法:
- 卡梅利德免疫和酵母表面显示图书馆的建设.
- 用标记EGF Fc融合蛋白进行光激活细胞分类 (FACS),用于全oster克隆选择.
- 结合亲和度测试和下游信号通路抑制研究 (PI3K/AKT,MAPK/ERK).
主要成果:
- 确定了11种结合EGFR而与EGF无竞争的重链抗体.
- 抗体表现出对EGFR表达细胞的皮科摩拉到纳米摩拉结合亲缘关系.
- 一个抗体显示,与 cetuximab 相比,EGF 诱导的 PI3K/AKT 和 MAPK/ERK 信号传递有更强的抑制作用.
结论:
- 阿洛斯特重链抗体代表了一种有前途的新型EGFR向治疗药物.
- 这些抗体调节EGFR活性,并有效地抑制下游信号通路.
- 鉴定到的抗体表现出增强的功效,这表明癌症治疗的治疗潜力显著.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.8K
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
8.6K
相关概念视频
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:08Allosteric Regulation
57.7K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.7K